Active Ingredient History

NOW
  • Now
Imexon is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.   Wikipedia

  • SMILES: N=C1NC(=O)N2CC12
  • InChIKey: BIXBBIPTYBJTRY-UHFFFAOYSA-N
  • Mol. Mass: 111.1
  • ALogP: -0.63
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
4-amino-1,3-diazabicyclo(3.1.0)hex-3-en-2-one | 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one | amplimexon | bm 06002 | bm-06002 | imexon

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue